FOCUS ISSUE: CARDIAC IMAGING: CLINICAL RESEARCH
Noninvasive Characterization of Myocardial Molecular Interventions by Integrated Positron Emission Tomography and Computed Tomography
Bettina Wagner, DVM*,
Martina Anton, PhD ,
Stephan G. Nekolla, PhD*,
Sybille Reder, MT*,
Julia Henke, DVM ,
Stefan Seidl, MD ,
Renate Hegenloh, MT ,
Masao Miyagawa, MD*,
Roland Haubner, PhD*,
Markus Schwaiger, MD* and
Frank M. Bengel, MD*,||,*
* Nuklearmedizinische Klinik und Poliklinik
Institut für Experimentelle Onkologie und Therapieforschung
Institut für Allgemeine Pathologie und Pathologische Anatomie
Abteilung für Gefäßchirurgie, Technische Universität München, Germany
|| Division of Nuclear Medicine, Johns Hopkins University, Baltimore, Maryland
Manuscript received July 31, 2006;
accepted August 30, 2006.
* Reprint requests and correspondence: Dr. Frank M. Bengel, Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University Medical Institutions, 601 N. Caroline Street, JHOC 3225, Baltimore, Maryland 21287. (Email: fbengel1{at}jhmi.edu).
OBJECTIVES: We sought to investigate the usefulness of integrated positron emission tomography (PET) and computed tomography (CT) for in vivo characterization of an angiogenesis-directed molecular intervention.
BACKGROUND: Controversies about the effectiveness of molecular therapies for cardiovascular disease have prompted the need for more powerful noninvasive imaging techniques.
METHODS: In a model of regional adenoviral transfer of the VEGF121 gene to myocardium of healthy pigs, PET-CT using multiple molecular-directed radiotracers was employed.
RESULTS: Two days after gene transfer, successful transgene expression was noninvasively confirmed by a reporter probe targeting co-expressed HSV1-sr39tk reporter gene. The CT-derived ventricular function and morphology remained unaltered (left ventricular ejection fraction 57 ± 5% in adenovirus-injected animals vs. 53 ± 5% in controls; p = 0.36). Increased regional perfusion was identified in areas overexpressing VEGF (myocardial blood flow during adenosine-induced vasodilation 1.47 ± 0.49 vs. 1.14 ± 0.27 ml/g/min in remote areas; p = 0.01), corroborating in vivo effects on microvascular tone and permeability. Finally, regional angiogenesis-associated vß3 integrin expression was not enhanced, suggesting little contribution to the perfusion increase. Fusion of CT morphology and tracer-derived molecular signals allowed for accurate regional localization of biologic signals. Findings were validated by control vectors, sham-operated animals, and ex vivo tissue analysis.
CONCLUSIONS: Integrated PET-CT has the potential to dissect cardiovascular biologic mechanisms from gene expression to physiologic function and morphology. The VEGF overexpression in healthy myocardium increases myocardial perfusion without significant up-regulation of vß3 integrin adhesion molecules early after the intervention.
|
Abbreviations and Acronyms
| | Adsr39tk
= replication defective type 5 adenovirus expressing a mutant herpesviral thymidine kinase reporter gene | | AdTk-VEGF
= replication defective type 5 adenovirus co-expressing a mutant herpesviral thymidine kinase reporter gene and the human VEGF121 gene | | AdVEGF
= replication defective type 5 adenovirus expressing the human VEGF121 gene | | CT = computed tomography | | FHBG = [18F]fluoro-hydroxymethylbutyl-guanine | | MBF = myocardial blood flow | | PET = positron emission tomography | | VEGF = vascular endothelial growth factor |
|
This article has been cited by other articles:

|
 |

|
 |
 
O. Gaemperli, F. M. Bengel, and P. A. Kaufmann
Cardiac hybrid imaging
Eur. Heart J.,
September 1, 2011;
32(17):
2100 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Dobrucki, E. D. de Muinck, J. R. Lindner, and A. J. Sinusas
Approaches to Multimodality Imaging of Angiogenesis
J. Nucl. Med.,
May 1, 2010;
51(Supplement_1):
66S - 79S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oostendorp, K. Douma, A. Wagenaar, J. M.G.M. Slenter, T. M. Hackeng, M. A.M.J. van Zandvoort, M. J. Post, and W. H. Backes
Molecular Magnetic Resonance Imaging of Myocardial Angiogenesis After Acute Myocardial Infarction
Circulation,
February 16, 2010;
121(6):
775 - 783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Bengel
Clinical Cardiovascular Molecular Imaging
J. Nucl. Med.,
June 1, 2009;
50(6):
837 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
56 - 70.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al.
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
Cardiovasc Res,
November 1, 2008;
80(2):
165 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Knuuti and F M Bengel
Positron emission tomography and molecular imaging
Heart,
March 1, 2008;
94(3):
360 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Johnson, L. Schofield, T. Donahay, M. Bouchard, A. Poppas, and R. Haubner
Radiolabeled RGD Peptides to Image Angiogenesis in Swine Model of Hibernating Myocardium.
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1:
500 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
 |
|
|